Form 8-K · Current report
AT&T 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0000732717
- Accession no.
- 0001193125-26-332110
Summary
AT&T closed its sale of €4.1 billion and £550 million in global notes across five tranches, with maturities from 2030 to 2052, under an underwriting agreement with Barclays, Citigroup, Goldman Sachs and Wells Fargo dated July 27, 2026.
Key points
- Tranches: €1bn 3.600% notes due 2030, €1.25bn 4.150% due 2034, €1bn 4.550% due 2038, €850m 5.050% due 2045, and £550m 7.050% due 2052.
- The notes were issued under a May 15, 2013 indenture with The Bank of New York Mellon Trust Company, N.A. as trustee.
- Barclays Bank PLC, Citigroup Global Markets Limited, Goldman Sachs & Co. LLC and Wells Fargo Securities International Limited were representatives of the underwriters.
- AT&T filed the 8-K to incorporate the documents by reference into its Form S-3 registration statement.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. On August 3, 2026, AT&T Inc. (“AT&T”) closed its sale of €1,000,000,000 aggregate principal amount of its 3.600% Global Notes due 2030, €1,250,000,000 aggregate principal amount of its 4.150% Global Notes due 2034, €1,000,000,000 aggregate principal amount of its 4.550% Global Notes due 2038, €850,000,000 aggregate principal amount of its 5.050% Global Notes due 2045 and £550,000,000 aggregate principal amount of its 7.050% Global Notes due 2052 pursuant to an Underwriting Agreement, dated July 27, 2026 (the “Underwriting Agreement”), between AT&T and Barclays Bank PLC, Citigroup Global Markets Limited, Goldman Sachs & Co. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.